Quantbot Technologies LP Acquires 6,389 Shares of Danaher Corporation $DHR

Key Points

• Quantbot Technologies LP increased its holdings in Danaher Corporation by 51.5% in the first quarter, owning a total of 18,799 shares valued at approximately $3.85 million.
• Institutional ownership of Danaher is strong, with about 79.05% of the stock held by various investors, including those rapidly increasing their stakes like Aptus Capital Advisors LLC, which raised its holdings by 1,396.2%.
• Danaher Corporation reported earnings of $1.80 per share for the last quarter, exceeding analyst expectations, and forecasts for the fiscal year suggest an EPS of around 7.63.

Quantbot Technologies LP grew its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 51.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,799 shares of the conglomerate's stock after buying an additional 6,389 shares during the quarter. Quantbot Technologies LP's holdings in Danaher were worth $3,854,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Aptus Capital Advisors LLC raised its holdings in shares of Danaher by 1,396.2% in the 1st quarter. Aptus Capital Advisors LLC now owns 105,903 shares of the conglomerate's stock valued at $21,710,000 after purchasing an additional 98,825 shares during the period. HFR Wealth Management LLC raised its holdings in shares of Danaher by 1.9% in the 1st quarter. HFR Wealth Management LLC now owns 40,839 shares of the conglomerate's stock valued at $8,372,000 after purchasing an additional 773 shares during the period. Seven Mile Advisory raised its holdings in shares of Danaher by 6.5% in the 1st quarter. Seven Mile Advisory now owns 1,483 shares of the conglomerate's stock valued at $304,000 after purchasing an additional 91 shares during the period. Corient IA LLC bought a new stake in shares of Danaher in the 1st quarter valued at about $308,000. Finally, Northwest & Ethical Investments L.P. raised its holdings in shares of Danaher by 42.0% in the 1st quarter. Northwest & Ethical Investments L.P. now owns 5,140 shares of the conglomerate's stock valued at $1,054,000 after purchasing an additional 1,520 shares during the period. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Evercore ISI dropped their target price on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. Leerink Partners upped their target price on shares of Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a report on Wednesday, April 23rd. Jefferies Financial Group dropped their target price on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target on the stock in a research note on Friday, July 11th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Seventeen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.

Danaher Stock Up 1.5%

Shares of DHR opened at $212.2350 on Wednesday. The firm's 50-day simple moving average is $200.33 and its 200 day simple moving average is $199.54. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The firm has a market cap of $151.97 billion, a P/E ratio of 45.16, a price-to-earnings-growth ratio of 2.92 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same quarter in the prior year, the business posted $1.72 EPS. The business's revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.